Biodesix to Report Second Quarter 2024 Financial Results on August 7, 2024
This Biodesix Insider Increased Their Holding In The Last Year
Lake Street Maintains Biodesix(BDSX.US) With Buy Rating, Maintains Target Price $3
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Biodesix (BDSX) and CVRx (CVRX)
Biodesix Named to Inc. Magazine's 2024 "Best Workplaces"
Biodesix to Participate in Two Investor Conferences in June
Biodesix to Present New Data on the Nodify XL2 Test at ATS 2024 Annual Meeting
Biodesix Initiated at Buy by TD Cowen
Biodesix Analyst Ratings
Buy Rating Justified by Biodesix's Market Leadership and Strong Growth Prospects
Express News | Biodesix Inc : TD Cowen Initiates With Buy Rating; Price Target $2.8
Biodesix(BDSX.US) Officer Sells US$642.1 in Common Stock
Biodesix(BDSX.US) Officer Sells US$361 in Common Stock
Biodesix(BDSX.US) Officer Sells US$692.41 in Common Stock
Biodesix(BDSX.US) Officer Sells US$5,568.84 in Common Stock
Biodesix(BDSX.US) Officer Sells US$1,449.91 in Common Stock
Biodesix Inc (BDSX) Surpasses Analyst Revenue Forecasts With Strong Q1 2024 Performance
Earnings Call Summary | Biodesix(BDSX.US) Q1 2024 Earnings Conference
Biodesix, Inc. (BDSX) Q1 2024 Earnings Call Transcript
Analysts Offer Insights on Healthcare Companies: GoodRx Holdings (GDRX), Petiq (PETQ) and Biodesix (BDSX)